TEL-AVIV, Israel, Feb. 8, 2022 /PRNewswire/ — This award recognizes how RightHear’s solution empowers the visually impaired and blind community to lead fully independent lives.
In the Startup Challenge, Konnect and Volkswagen Commercial Vehicles screened more than 30 Israeli startups. In the final round 10 of them pitched in front of a team of experts from Konnect and VW Commercial Vehicles in Germany. RightHear won a €25,000 proof-of-concept with VW Commercial Vehicles, for helping people with navigation and orientation challenges better access their environments.
RightHear’s technology leverages Bluetooth iBeacons which are strategically installed in public venues to provide “talking signage”. Users receive real-time, geo-specific information directly to their smartphones via the RightHear app, helping them navigate their environment confidently and safely. And it’s all completely free.
“As a leading Mobility-as-a-Service provider, It is crucial for us to offer services that are accessible for all of our customers” said Dr. Astrid Wollenberg, Managing Director at Konnect – Volkswagen Group Innovation Hub TLV. “RightHear’s vision and technology will allow us to offer a more inclusive environment in our vehicles and mobility services.”
Idan Meir, Co-Founder and CEO at RightHear said, “We’re honored to have been awarded this recognition. We are excited for this incredible partnership with VW, to help create accessible autonomous vehicles together.”
RightHear is helping many sectors, including travel, retail, and hospitality to adapt their physical spaces so anyone and everyone – regardless of their challenges – can experience life equally.
Learn more about this recent partnership on the RightHear blog!
SOURCE RightHear
GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through…
RLT_Angels Photo RLT Angels Association Further founding members include the European Association of Nuclear Medicine…
From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major…
Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD,…
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity –…
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
